BackTable Tumor Board
Episodes
Ep. 40 Advanced Surgical Approaches in Lung Cancer Management with Dr. Scott Atay and Dr. Scott Oh
16 Dec 2025
Contributed by Lukas
Is the open thoracotomy becoming outdated as robotic surgery and advanced ablation techniques take center stage in lung cancer treatment? In the final...
Ep. 39 Biopsy and Ablation Decision-Making in Lung Cancer with Drs. Alan Lee, Scott Oh, Rob Suh
09 Dec 2025
Contributed by Lukas
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery isn’t an option? In the penultim...
Ep. 38 Lung Ablation: Techniques, Challenges & Best Practices with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh
02 Dec 2025
Contributed by Lukas
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central lung lesions that were previously...
Ep. 37 Ablative Treatments & Radiotherapy: The Latest in Lung Cancer Treatment with Dr. Alan Lee, Dr. Scott Oh, and Dr. Rob Suh
25 Nov 2025
Contributed by Lukas
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look for instead? In the 4th install...
Ep. 36 Lung Cancer Staging & Systemic Therapies: Recent Advancements with Dr. Karen Reckamp and Dr. Scott Atay
18 Nov 2025
Contributed by Lukas
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung cancer patient’s treatment plan...
Ep. 35 NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee
14 Nov 2025
Contributed by Lukas
When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first? Part two of the 2025 NSCLC Cre...
Ep. 34 Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, and Dr. Alan Lee
11 Nov 2025
Contributed by Lukas
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking off the 2025 NSCLC Creator Wee...
Ep. 33 Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer with Dr. Adam Luginbuhl, Dr. Jennifer Johnson, Dr. Mihir Patel and Dr. Siddharth Sheth
04 Nov 2025
Contributed by Lukas
When treating head and neck cancer, how can you tell the difference between true disease progression and pseudoprogression? In this episode of the Bac...
Ep. 32 Understanding Keynote-689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden, Dr. Ravi Uppaluri and Dr. Adam Luginbuhl
28 Oct 2025
Contributed by Lukas
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing cli...
S03 Ep. 31 NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka
07 Oct 2025
Contributed by Lukas
One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder and the ureter? In the final ep...
S03 Ep. 30 NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka
07 Oct 2025
Contributed by Lukas
When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern treatments, biomarkers, and clin...
S03 Ep. 29 Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue
07 Oct 2025
Contributed by Lukas
With the right protocols (and the right team!), urology clinics can proactively manage the side effects of intravesical therapy. This in-studio episod...
S03 Ep. 28 How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka
07 Oct 2025
Contributed by Lukas
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for invasive cystoscopies? In part...
S03 Ep. 27 Non-Muscle Invasive Bladder Cancer: Role of Medical Oncology with Dr. Tyler Stewart
07 Oct 2025
Contributed by Lukas
With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on point for planning, administerin...
S03 Ep. 26 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
07 Oct 2025
Contributed by Lukas
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do yo...
S03 Ep. 25 Guide to Patient-Centered Counseling in NMIBC Care with Dr. Sima Porten and Dr. Pat Hensley
07 Oct 2025
Contributed by Lukas
When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and treatment plan to their individual...
S03 Ep. 24 Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal
07 Oct 2025
Contributed by Lukas
How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and management of non-muscle invasi...
S02 Ep. 23 Renal Cancer Management: Tumor Board Discussion & Treatments with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay
23 Sep 2025
Contributed by Lukas
Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley (Urologic Oncology, M...
S02 Ep. 22 Multidisciplinary Spine Oncology Care: Insights and Techniques with Dr. Ran Lador and Dr. Mark Amsbaugh
16 Sep 2025
Contributed by Lukas
When it comes to spinal oncology, no single specialty holds all the answers. In this episode of the BackTable Podcast, host Dr. Alexa Levey, an interv...
S02 Ep. 21 Prostate Tumor Board: Risk Stratification & Treatment Strategies with Dr. Neeraj Agarwal and Dr. Tyler Seibert
19 Aug 2025
Contributed by Lukas
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of BackTable Tumor Board, leading pr...
S02 Ep. 20 BCG Shortage: Salvaging Bladder Cancer Care When Standard Care Is Scarce with Dr. Amy Luckenbaugh
22 Jul 2025
Contributed by Lukas
How do you effectively treat your bladder cancer population with an insufficient supply of BCG? Dr. Amy Luckenbaugh, a urologic oncologist at Vanderbi...
S02 Ep. 19 Intravesical Therapies for Intermediate Risk Bladder Cancer with Dr. Lindsey Herrel
17 Jun 2025
Contributed by Lukas
With BCG in short supply and recurrence rates still high, the race is on for better intravesical options. In this episode of BackTable Tumor Board, Dr...
S02 Ep. 18 Intermediate Risk NMIBC: Patient-Centered Treatment Strategies with Dr. Kelly Bree
10 Jun 2025
Contributed by Lukas
Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways...
S02 Ep. 17 Penile Cancer Management: Insights and Case Studies with Dr. Juanita Crook and Dr. Andrea Apolo
03 Jun 2025
Contributed by Lukas
How do the experts balance organ preservation, oncologic control, and emerging therapies in both localized and metastatic cases of penile cancer? This...
S02 Ep. 16 Insights on Management of Upper Tract Urothelial Cancer with Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
27 May 2025
Contributed by Lukas
With so many treatment modalities for upper tract urothelial carcinoma, how does new evidence inform optimal care? In this episode of BackTable Tumor ...
S02 Ep. 15 Integrative Oncology in Urologic Cancer Care with Dr. Viraj Master
27 May 2025
Contributed by Lukas
What if the key to better cancer outcomes lies not just in surgery or chemotherapy, but also in mindfulness, movement, and diet? In this episode of th...
S02 Ep. 14 Multidisciplinary Approaches to Pediatric Urologic Cancer Care with Dr. David Rodeberg and Dr. Patrick Hensley
27 May 2025
Contributed by Lukas
How can pediatric and adult urologists team up to tackle complex cancer cases? In this episode of the BackTable Tumor Board, host Dr. Amanda Buchanan,...
S02 Ep. 13 Multidisciplinary Approaches to Renal Cancer Care with Dr. Louis Hinshaw and Dr. Jason Abel
27 May 2025
Contributed by Lukas
How can urologists and radiologists work together to improve kidney cancer treatment? In this episode, BackTable Tumor Board brings together Dr. Jason...
S02 Ep. 12 Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors with Dr. Nabil Adra and Dr. Richard Matulewicz
27 May 2025
Contributed by Lukas
What does it take to deliver truly personalized, multidisciplinary care in testicular cancer? Get an inside look in this episode of BackTable Tumor Bo...
S01 Ep. 11 Immunotherapy and TACE in HCC Treatment with Dr. Julius Chapiro and Dr. Richard Finn
29 Apr 2025
Contributed by Lukas
There are now multiple phase 3 studies on combination transarterial chemoembolization (TACE) and immunotherapy showing a significant benefit over TACE...
S01 Ep. 10 Collaborative Oncology: Surgeon’s Perspective and Role in Locoregional Therapy with Dr. Robert Martin
11 Mar 2025
Contributed by Lukas
Medical, surgical, radiation, and interventional oncology all play vital roles in delivering care to patients battling liver cancer. How do we optimiz...
S01 Ep. 9 Principles to Practice: An HCC Tumor Board
17 Jan 2025
Contributed by Lukas
Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s vie...
S01 Ep. 8 Getting Started in Interventional Oncology: Tips for Starting Your Career
17 Jan 2025
Contributed by Lukas
Are you seeking to build your reputation and patient base within interventional oncology? In this episode, host Dr. Zachary Berman interviews Dr. Sidd...
S01 Ep. 7 Surgery for HCC: What’s Its Role Today?
17 Jan 2025
Contributed by Lukas
Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr. Sabeen Dhand leads a roundtable d...
S01 Ep. 6 Transplantation for HCC: Who, When, and How?
17 Jan 2025
Contributed by Lukas
The process of liver transplantation involves many complexities, and each patient's path to transplant is unique. To offer insider perspectives on thi...
S01 Ep. 5 Complex HCC Patients and the "Grey Zone": What To Do When You Don’t Know What To Do
17 Jan 2025
Contributed by Lukas
Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "gre...
S01 Ep. 4 Curative Intent Therapies for HCC: Today and Tomorrow
17 Jan 2025
Contributed by Lukas
For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. Wit...
S01 Ep. 3 Combination Therapy and Clinical Trials for Advanced HCC: What They Really Mean
17 Jan 2025
Contributed by Lukas
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors ...
S01 Ep. 2 How to Simplify Dosing: Understanding Y-90 Dosimetry from Simple to Complex
17 Jan 2025
Contributed by Lukas
Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In t...
S01 Ep. 1 Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics
17 Jan 2025
Contributed by Lukas
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (inter...